Health-care today is all about integration, with patients and providers increasingly linked through electronic health records. Yet tension still exists between patient privacy concerns and improved access to records, especially when it comes to substance abuse records.
A recent final rule from the Substance Abuse and Mental Health Services Administration attempts to thread the needle by giving providers more leeway to disclose substance abuse records while retaining privacy protections.
The guidance underlines when substance abuse records can be disclosed for payment, operations, and audit purposes, and also authorizes providers to use a shorter notice prohibiting the re-disclosure of patient records.
SAMHSA also issued a January 2017 final rule that also eased substance abuse disclosures by letting patients give a general consent to the disclosure of their records instead of requiring individual consent every time a record was shared.
Until last year’s final rule, Part 2 substance abuse regulations hadn’t been updated since before the creation of the Health Insurance Portability and Accountability Act, Eric Fader, a health-care attorney with Day Pitney LLP in New York, told me.
Part 2 refers to the section of the U.S. Code of Federal Regulations (42 CFR Part 2) covering the confidentiality of patients’ alcohol and drug abuse records.
“Industry awareness and compliance with HIPAA and the HITECH Act, and the available regulatory guidance concerning HIPAA, were far ahead of those for Part 2, so the new rule will certainly improve compliance with Part 2,” Fader said.
The new rule highlights SAMHSA’s efforts give providers more flexibility in disclosing alcohol and drug abuse records, W. Reece Hirsch, a health-care attorney with Morgan, Lewis & Bockius LLP in San Francisco, told me recently.
Read my full story here.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)